| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8770343 | Journal of Renal Nutrition | 2018 | 9 Pages |
Abstract
Aprobiotic supplementation failed to reduce uremic toxins and inflammatory markers. Therefore, probiotic therapy should be chosen with caution in HD patients. Further studies addressing probiotic therapy in chronic kidney disease patients are needed.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Natália A. PhD, Flávia L. PhD, Milena B. PhD, Jessyca S. MSc, Carla J. MSc, Dennis C. PhD, Lia S. PhD, Alexandre PhD, Denis MD, PhD, Denise PhD,